Results 71 to 80 of about 1,110 (213)

User Classification and Traffic Steering in O-RAN

open access: yesIEEE Open Journal of the Communications Society
The O-RAN architectural framework enables the application of AI/ML techniques for traffic steering and load balancing. Indeed, an effective steering technique is crucial to avoiding ping-pong and radio link failure. Limited observability and network complexity make it challenging to understand individual user needs.
Ntassah, Rawlings   +2 more
openaire   +4 more sources

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

RRC Signaling Storm Detection in O-RAN

open access: yes2025 IEEE Symposium on Computers and Communications (ISCC)
The Open Radio Access Network (O-RAN) marks a significant shift in the mobile network industry. By transforming a traditionally vertically integrated architecture into an open, data-driven one, O-RAN promises to enhance operational flexibility and drive innovation.
Dang Kien Nguyen   +2 more
openaire   +3 more sources

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Security Threats to xApps Access Control and E2 Interface in O-RAN

open access: yesIEEE Open Journal of the Communications Society
Open Radio Access Networks (O-RANs) represent a novel wireless access network architecture that decomposes traditional RAN functions and makes them openly accessible.
Cheng-Feng Hung   +3 more
doaj   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

A Survey and an Analysis of Conflict Management in O-RAN

open access: yesIEEE Open Journal of the Communications Society
The emergence of the Open Radio Access Network (O-RAN) introduces unprecedented flexibility, programmability, and multi-vendor interoperability into cellular systems.
Francielly De Souza Almeida   +5 more
doaj   +1 more source

Advancing O-RAN to Facilitate Intelligence in V2X

open access: yesIEEE Network
Vehicular communications integrated with the Radio Access Network (RAN) are envisioned as a breakthrough application for the 6th generation (6G) cellular systems. However, traditional RANs lack the flexibility to enable sophisticated control mechanisms that are demanded by the strict performance requirements of the vehicle-to-everything (V2X ...
Eugenio Moro   +4 more
openaire   +2 more sources

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy